AZD8797

Item number	Size	Delivery time	Price
TGM-T14384-1mg	1 mg	7 - 10 business days*	76.00€
TGM-T14384-5mg	5 mg	7 - 10 business days*	187.00€
TGM-T14384-1mL	1 ml	7 - 10 business days*	207.00€
TGM-T14384-10mg	10 mg	7 - 10 business days*	279.00€
TGM-T14384-25mg	25 mg	7 - 10 business days*	490.00€
TGM-T14384-50mg	50 mg	7 - 10 business days*	686.00€
TGM-T14384-100mg	100 mg	7 - 10 business days*	934.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: AZD8797 (KAND567) is an orally available, selective and potent human... more

Close menu

Product information "AZD8797"

Description: AZD8797 (KAND567) is an orally available, selective and potent human CX3CR1-converting antagonist with inhibitory effects on CX3CR1 and CXCR2, and potentially protects against SARS-CoV-2-induced neuronal damage, preventing worsening of nociceptive sensitization and microglial activation in a migraine model of rats following seizures. Target: CXCR. Smiles: CC(C)C[C@H](CO)Nc1nc(S[C@@H](C)c2ccccc2)nc2nc(N)sc12. References: Cederblad L, et al. AZD8797 is an allosteric non-competitive modulator of the human CX3CR1 receptor. Biochem J. 2016 Mar 1,473(5):641-9.

Keywords:	KAND567, KAN-0440567
Supplier:	TargetMol
Supplier-Nr:	T14384

Properties

Application:	CX3CR1 antagonist
MW:	403.56 D
Formula:	C19H25N5OS2

Database Information

CAS :	911715-90-7\| Matching products
KEGG ID :	K04192 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "AZD8797"

Write a review